Who are Alumis Inc.'s main suppliers?

Alumis Inc. (ALMS) key suppliers include: FRONTHERA-U-S-HOLDINGS-INC, ORANY, ORANY. View the full supplier network at chainsifter.com/chain/ALMS.

Who are Alumis Inc.'s major customers?

Alumis Inc. (ALMS) key customers include: KAKEN, Climb Bio, Inc., Climb Bio, Inc.. View the full customer network at chainsifter.com/chain/ALMS.

What sector is Alumis Inc. in?

Alumis Inc. (ALMS) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Alumis Inc. Suppliers, Customers & Supply Chain (ALMS)

3Suppliers

3Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

Alumis Inc. (ALMS) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

8Total relationships

3Distinct source URLs

4High confidence

0.813Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Alumis Inc. Suppliers

Ticker	Name	Confidence	Evidence
FRONTHERA-U-S-HOLDINGS-INC	FRONTHERA-U-S-HOLDINGS-INC	90%	In March 2021, the Company entered into a stock purchase agreement to acquire FronThera U.S. Holdings, Inc. and its wholly owned subsidiary, FronThera U.S. Pharmaceuticals LLC.
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from ALMS graph: available for physicians to prescribe. After that, the MHLW lists its National Health Insurance price within 60 days…
ORANY	ORANY	72%	available for physicians to prescribe. After that, the MHLW lists its National Health Insurance price within 60 days (or 90 days at the latest) from the approval, and physicians can obtain reimbursem…

Alumis Inc. Customers

Ticker	Name	Confidence	Evidence
KAKEN	KAKEN	92%	All of the Company's revenues are currently earned under its license and collaboration agreement with Kaken.
CLYM	Climb Bio, Inc.	72%	Reciprocal relationship from CLYM graph: Reciprocal relationship from ALMS graph: ted ACELYRIN stock options and RSUs continue to vest in accordance with their original terms. Performance RSUs were d…
CLYM	Climb Bio, Inc.	72%	ted ACELYRIN stock options and RSUs continue to vest in accordance with their original terms. Performance RSUs were deemed to have 100 % satisfied their performance conditions and will vest in two eq…

Alumis Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
ALMS-DEBT	Debt stack $35.7M	90%	Market cache reports total debt of $35.7M.

Alumis Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Alumis Inc..

Alumis Inc. Ownership

Holder	Name	Confidence	Evidence
ALMS-OWNER-VANGUARD-CAPITAL-MANAGEMENT-LLC	VANGUARD CAPITAL MANAGEMENT LLC	90%	13F overlay lists VANGUARD CAPITAL MANAGEMENT LLC as top holder; 199 tracked holders.

Alumis Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
CLYM	Climb Bio, Inc.	100.00	1	['customer']
ORANY	ORANGE	100.00	1	['supplier']
KAKEN	KAKEN	63.48	1	['receiving']
BCDRF	Banco Santander, S.A.	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
BFRIW	Biofrontera Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
AMXOF	AMERICA MOVIL SAB DE CV/	50.00	2
CINGW	Cingulate Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
BDRX	Biodexa Pharmaceuticals Plc	50.00	2

Alumis Inc. Supply Chain